Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca
  1. Pubblicazioni

Nutritional Status on Chemotherapy Delivery and Outcomes in Advanced Pancreatic Cancer: A Prospective Multicenter Study

Articolo
Data di Pubblicazione:
2026
Citazione:
Nutritional Status on Chemotherapy Delivery and Outcomes in Advanced Pancreatic Cancer: A Prospective Multicenter Study / A, Maria Kiriukova; B, Giulia Orsi; C, Vasile Sandru; D, Daniel De La Iglesia; E, Nikola Panic; F, Maryana Bozhychko; G, Bartu Avci; H, Alice Burini; H, Sara Cardellini; H, Valeria Loliva; I, Livia Archibugi; B, Marina Macchini; C, Afrodita Panaitescu-Damian; A, Dmitry Bordin; Arcidiacono, Paolo Giorgio; K, Patrick Maisonneuve; F L M, Enrique de-Madaria; Reni, Michele; Capurso, Gabriele. - In: CLINICAL NUTRITION. - ISSN 0261-5614. - 57:(2026). [10.1016/j.clnu.2025.106573]
Abstract:
Background & aim: Malnutrition is common in pancreatic ductal adenocarcinoma (PDAC) and may compromise chemotherapy delivery. We investigated whether baseline nutritional status and quality of life (QoL) predict chemotherapy relative dose intensity (RDI) and survival in advanced PDAC. Methods: In this multicenter prospective cohort, adults with locally advanced or metastatic PDAC planned for first-line chemotherapy underwent baseline nutritional and QoL assessments, including the Mini Nutritional Assessment (MNA), European Organisation for Research and Treatment of Cancer-Pancreas 26 (EORTC-PAN26), and Functional Assessment of Anorexia/Cachexia Therapy subscale (FAACT-A/CS). The primary outcome was chemotherapy delivery during the first 12 weeks, expressed as RDI. Secondary outcomes included overall survival (OS). Associations between baseline scores, RDI, and OS were analyzed using regression models adjusted for age, sex, disease stage, and center. Kaplan–Meier and Cox models assessed survival. Results: Of 140 enrolled patients, 105 started chemotherapy. Malnutrition was frequent (55.7 % at risk, 33.6 % malnourished). Higher MNA and EORTC-PAN26 scores were associated with better RDI (r = 0.31, p = 0.001; r = 0.30, p = 0.002), whereas FAACT-A/CS showed no correlation. In multivariable analysis, higher MNA scores [odds ratio (OR) 0.55; 95 % confidence interval (CI) 0.32–0.96; p = 0.036] and metastatic disease (OR 0.36; 95 % CI 0.13–0.99; p = 0.048) independently predicted RDI ≥80 %. Reduced RDI (hazard ratio [HR] 2.05; 95 % CI 1.20–3.50; p = 0.009) and FAACT-A/CS < 28 (HR 1.90; 95 % CI 1.04–3.49) were independently associated with shorter OS. Conclusions: Baseline nutritional status and QoL, particularly assessed by MNA and EORTC-PAN26, predict chemotherapy delivery in advanced PDAC. Reduced RDI and anorexia/cachexia symptoms are linked to poorer survival, supporting systematic nutritional assessment and targeted interventions to optimize outcomes.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
A, Maria Kiriukova; B, Giulia Orsi; C, Vasile Sandru; D, Daniel De La Iglesia; E, Nikola Panic; F, Maryana Bozhychko; G, Bartu Avci; H, Alice Burini; H, Sara Cardellini; H, Valeria Loliva; I, Livia Archibugi; B, Marina Macchini; C, Afrodita Panaitescu-Damian; A, Dmitry Bordin; Arcidiacono, Paolo Giorgio; K, Patrick Maisonneuve; F L M, Enrique de-Madaria; Reni, Michele; Capurso, Gabriele
Autori di Ateneo:
ARCIDIACONO PAOLO GIORGIO
CAPURSO GABRIELE
RENI MICHELE
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/195377
Pubblicato in:
CLINICAL NUTRITION
Journal
  • Dati Generali

Dati Generali

URL

https://www.sciencedirect.com/science/article/pii/S026156142500353X?via=ihub
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0